1. Home
  2. RYTM vs DY Comparison

RYTM vs DY Comparison

Compare RYTM & DY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • DY
  • Stock Information
  • Founded
  • RYTM 2008
  • DY 1969
  • Country
  • RYTM United States
  • DY United States
  • Employees
  • RYTM N/A
  • DY N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • DY Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • RYTM Health Care
  • DY Industrials
  • Exchange
  • RYTM Nasdaq
  • DY Nasdaq
  • Market Cap
  • RYTM 5.9B
  • DY 5.3B
  • IPO Year
  • RYTM 2017
  • DY N/A
  • Fundamental
  • Price
  • RYTM $88.64
  • DY $258.73
  • Analyst Decision
  • RYTM Strong Buy
  • DY Strong Buy
  • Analyst Count
  • RYTM 13
  • DY 11
  • Target Price
  • RYTM $89.77
  • DY $241.45
  • AVG Volume (30 Days)
  • RYTM 1.0M
  • DY 261.7K
  • Earning Date
  • RYTM 08-05-2025
  • DY 08-20-2025
  • Dividend Yield
  • RYTM N/A
  • DY N/A
  • EPS Growth
  • RYTM N/A
  • DY 1.66
  • EPS
  • RYTM N/A
  • DY 7.89
  • Revenue
  • RYTM $136,863,000.00
  • DY $4,818,199,000.00
  • Revenue This Year
  • RYTM $37.47
  • DY $17.80
  • Revenue Next Year
  • RYTM $71.16
  • DY $8.07
  • P/E Ratio
  • RYTM N/A
  • DY $32.02
  • Revenue Growth
  • RYTM 48.88
  • DY 12.77
  • 52 Week Low
  • RYTM $40.61
  • DY $131.37
  • 52 Week High
  • RYTM $94.80
  • DY $260.84
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 71.18
  • DY 70.89
  • Support Level
  • RYTM $87.86
  • DY $248.26
  • Resistance Level
  • RYTM $92.14
  • DY $260.83
  • Average True Range (ATR)
  • RYTM 3.57
  • DY 5.08
  • MACD
  • RYTM 1.01
  • DY -0.51
  • Stochastic Oscillator
  • RYTM 77.38
  • DY 91.71

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.

Share on Social Networks: